Nifedipine
Appearance
![]() | |||
| |||
Clinical data | |||
---|---|---|---|
Trade names | Adalat, Procardia, others | ||
AHFS/Drugs.com | Monograph | ||
MedlinePlus | a684028 | ||
License data |
| ||
Pregnancy category |
| ||
Routes of administration | By mouth, topical | ||
Drug class | Calcium channel blocker (dihydropyridine)[2] | ||
ATC code | |||
Pharmacokinetic data | |||
Bioavailability | 45-56% | ||
Protein binding | 92-98% | ||
Metabolism | Gastrointestinal, Liver | ||
Elimination half-life | 2 hours | ||
Excretion | Kidneys: >50%, bile duct: 5-15% | ||
Identifiers | |||
CAS Number | |||
PubChem CID | |||
IUPHAR/BPS | |||
DrugBank | |||
ChemSpider | |||
UNII | |||
KEGG | |||
ChEBI | |||
ChEMBL | |||
ECHA InfoCard | 100.040.529 | ||
(verify) |
Nifedipine (brand names: Adalat, Adipine, Coracten, Fortipine, Nifedipress) is a calcium channel blocker medicine used to treat high blood pressure (hypertension).[3]
In people with high blood pressure, taking nifedipine helps to prevent future heart disease, heart attacks and strokes.[3] Nifedipine is also used to prevent chest pain caused by angina. Occasionally, it is used to treat Raynaud's phenomenon and chilblains.[3]
Related pages
[change | change source]References
[change | change source]- ↑ "Nifedipine Pregnancy and Breastfeeding Warnings". Archived from the original on 21 December 2015. Retrieved 25 December 2015.
- ↑ "Nifedipine". The American Society of Health-System Pharmacists. Archived from the original on 8 August 2018. Retrieved 17 September 2019.
- ↑ 3.0 3.1 3.2 "About nifedipine". nhs.uk. 2022-02-25. Retrieved 2024-05-30.